PureHealth, recognized as the largest healthcare group in the Middle East, announced that its total investment in locally sourced goods and services has reached AED2.25 billion.

In the year 2024, PureHealth directed AED 1 billion into the national economy, representing a 38% increase compared to the previous year. This substantial investment is directly aligned with the UAE’s objectives to localize supply chains, promote national businesses, and accelerate economic diversification.

Shaista Asif, Group Chief Executive Officer of PureHealth, emphasized the importance of their investment in the UAE’s industrial ecosystem, stating that it is based on a long-term vision for healthcare resilience. She noted that by advancing their In-Country Value goals, they are localizing critical supply chains, supporting homegrown innovation, and enabling the development of advanced healthcare manufacturing capabilities. Asif highlighted that this initiative is not solely focused on current demands but aims to build a sustainable and self-sufficient healthcare system that will benefit UAE communities for generations.

The commitment of PureHealth to local industrial growth and innovation is evident in the strong In-Country Value (ICV) performance observed across its brands. SEHA holds the highest ICV score in the UAE healthcare sector at 81.13%, while Daman, the leading health insurer in the UAE, ranks second in the insurance sector with a score of 71.86%. Additionally, PureLab and The Medical Office (TMO) have secured their ICV certification, with Sheikh Shakhbout Medical City (SSMC) expected to receive certification later this year, marking progress towards full compliance across the PureHealth group.

These accomplishments reflect robust performance in areas such as procurement, Emiratisation, investment, and sustainability. All activities are reported to the Ministry of Industry and Advanced Technology (MoIAT) to ensure transparency and alignment with national priorities.

Leya Al Damani, Chief Sustainability Officer at PureHealth, remarked that sustainability and localization are interconnected. She emphasized that partnerships with UAE-based suppliers that adhere to their environmental and quality standards create long-term value for both the healthcare system and the national economy. Al Damani pointed out that the National In-Country Value Program provides a powerful framework to measure and responsibly scale this impact, while also fostering a supportive environment for the growth of small and medium-sized enterprises across the country.

PureHealth’s procurement strategy encompasses medical supplies, pharmaceuticals, technology, and infrastructure services, with a strong emphasis on collaborating with UAE-based suppliers who meet international standards and promote homegrown innovation. Through strategic offtake agreements and ongoing supplier development, the group continues to identify new opportunities for partnerships with local manufacturers, thereby driving industrial capacity, enhancing supply chain resilience, and advancing the UAE’s vision for a future-ready healthcare sector.